Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1600 1635 1637 1658 1674 4100
This examiner grants 71% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17318846 | MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING | Final Rejection | UNIVERSITY OF MASSACHUSETTS |
| 18061632 | TEMPLATE GUIDE RNA MOLECULES | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 17927485 | COMPOSITIONS AND METHODS FOR TRANSDIFFERENTIATING CELLS | Non-Final OA | The Regents of the University of California |
| 17604375 | EXOSOME MIMICKING NANOVESICLES MAKING AND BIOLOGICAL USE | Final Rejection | The Regents of the University of California |
| 18277969 | METHODS AND COMPOSITIONS TO CONFER REGULATION TO GENE THERAPY CARGOES BY HETEROLOGOUS USE OF ALTERNATIVE SPLICING CASSETTES | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18015108 | NUTRITIONAL COMPOSITION COMPRISING MIR-3184 | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18283615 | COMPOSITIONS AND METHODS FOR TARGETED SYSTEMIC DELIVERY TO CELLS | Non-Final OA | The Board of Regents of the University of Texas System |
| 18245256 | SYSTEMS FOR GENE EDITING AND METHODS OF USE THEREOF | Non-Final OA | Rutgers, The State University of New Jersey |
| 18286029 | IMPROVED COMPOSITIONS FOR DELIVERY OF MRNA | Non-Final OA | TRANSLATE BIO, INC. |
| 17508516 | COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION | Non-Final OA | Ionis Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy